Caplight Directory>Investors>National Institute of Allergy and Infectious Diseases>National-institute-of-allergy-and-infectious-diseases


National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

Rockville, Marylandniaid.nih.gov

Overview

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID plays a critical role in national and global health security, particularly through its leadership in responding to emerging infectious diseases. Its work includes the development of vaccines, therapeutics, and diagnostics, as well as supporting infrastructure for rapid response to health threats.

Year Founded

1955

Portfolio Companies

76

Investments

CompanyDateStageLead
NovAb, Inc.Apr 2026DebtCo-investor
Sunflower TherapeuticsSep 2025GrantCo-investor
Oregon Health & Science UniversityAug 2025GrantLead
L2 DiagnosticsAug 2025GrantLead
LactigaFeb 2025GrantCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRockville, Maryland
Year Founded1955

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.